MedPath

Comparative evaluation of efficacy of two bone grafts Sybograf C (Nanocrystalline Hydroxyapatite with natural Collagen) and Sybograf (Nanocrystalline Hydroxyapatite) in treatment of intrabony defects in alveolar bone in chronic periodontitis patients.

Phase 4
Completed
Conditions
Health Condition 1: null- Chronic Periodontitis
Registration Number
CTRI/2018/01/011302
Lead Sponsor
Dr Abhinav Deshpande
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1. Age group between 20-60years

2. Diagnosis with chronic periodontitis

3. Patients in good systemic health with no contraindication to periodontal surgery

4. Patients having intrabony defects with pocket depths of >5mm and with radiographic evidence of vertical / angular bone loss in the affected sites.

5. Patients who had not received any type of periodontal therapy for the past 6 months

6. Patients not taking any immuno-suppressive drugs like corticosteroids

7. Involved teeth to be vital and asymptomatic

Exclusion Criteria

1. One â?? wall osseous defects.

2. Patients suffering from any systemic diseases or with compromised immune system.

3. Patients with a known history of allergy to doxycycline or Chlorhexidine or any other medicine be used in the study.

4. Patients showing unacceptable oral hygiene compliance during / after the phase I therapy.

5. Patients taking any drug known to cause gingival enlargement.

6. Pregnant and/or lactating mothers.

7. Patients who were smokers or had tobacco in any other form.

8. Endodontically treated teeth.

9. Patient on anticoagulant therapy

10. Patient with bleeding disorders .

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath